Table 4.
Parent compound | Changed endogenous metabolites | Involved biological pathways | Experimental setup | Sample prep | Analytical conditions | Data evaluation | Reference |
---|---|---|---|---|---|---|---|
Cocaine | N-methylserotonin Guanine Hypoxanthine Anthranilate Xanthine |
Tryptophan metabolism Purine metabolism |
Targeted Human plasma Cocaine-dependent (n = 18) vs. healthy controls (n = 10) |
PP | Electrochemical detection electrochemical array platform LCECA |
R | Patkar et al., 2009 |
Crack | Lactate Long chain fatty acids acylated carnitines Histidine and tyrosine |
Nutritial behavior | Untargeted Human serum Crack-dependent vs. control group n = 44 per group |
Dilution | NMR 1H-NMR (1D, 600.173 MHz) T2-edited spectra of 1H NMR HSQC experiments for 1H–13C correlations |
Costa et al., 2018 | |
Heroin | myo-inositol-1-P threonate 9-z-hexadecenoic acid hydroxyproline |
Untargeted Rat serum/urine Control vs. heroin-treated n = 6 per group |
PP Derivatization CH3-O-NH2 MSTFA |
GC-MS DB5-MS (10 m × 0.18 mm) He EI/TOF Fullscan |
SIMCAP 11 | Zheng et al., 2013 | |
MA | Acute: Alanine Glycine Ornithine Asparagine Valine Isoleucine Leucine Serine Proline Threonine Methionine Citrulline Tryptophan Glutamine Glutamate Asparate Lysine Citrate 2-ketoglutarate Succinate Fumarate Malate Pyruvate Long term (5 days): Alanine Glycine Lysine Threonine Ornithine, hydroxyproline citrulline Fumarate Pyruvate Succinate Citrate 3-hydroxybutyrate 5-hydroxyindoleacetic 2 days after withdrawal Isoleucine Palmitic acid Creatinine Citrate 2-ketoglutarate Lactate |
Energy metabolism Amino acid metabolism TCA cycle Lipids and free fatty acids |
Untargeted Rat serum/urine Control vs. MA-treated n = 6 per group |
PP Derivatization CH3-O-NH2 MSTFA |
GC-MS RTx-5MS column (30 m × 0.25 mm) He EI Fullscan |
SIMCA-P 13 | Zheng et al., 2014 |